SecBot SecBot
PRESS-RELEASE ·Filed Mar 9, 2026

XRAY

DENTSPLY SIRONA Inc.
BULLISH
Impact 7/10
Horizonmonths Processed8mo ago WireGlobeNewswire
Press release · FDA
Actionable Insight ▲ Bullish

Traders should monitor upcoming commercial launch plans, pricing strategy, and adoption signals from academic and specialty dental centers. Initial revenue impact will likely be minimal, but this could establish a new imaging standard and open a premium segment in dental diagnostics over time.

DirectionBullish
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$12.80
T+0 close · Mar 9, 2026 · via day close
Latest settled
−23.20%
T+60 · $9.83
Vs SPY
−35.19%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 9 $12.80entry
  2. T+1 · 8mo ago −0.94%α −0.75% · $12.68
  3. T+5 · 8mo ago −8.36%α −7.00% · $11.73
  4. T+20 · 7mo ago −10.00%α −7.19% · $11.52
  5. T+60 · 6mo ago −23.20%α −35.19% · $9.83
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dentsply Sirona and Siemens Healthineers announced FDA clearance for the first dental-dedicated MRI (ddMRI) system, MAGNETOM Free.Max Dental Edition, following a clinical trial confirming its utility in endodontics, periodontics, TMJ, and orthodontics. The technology offers ionizing radiation-free imaging with advanced soft tissue contrast, positioning it as a complementary diagnostic tool for specialized dental applications. While not yet commercially available, the system represents a novel advancement in dental imaging with potential long-term clinical and commercial implications.

Key Facts

  • FDA has cleared the MAGNETOM Free.Max Dental Edition, the first dental-dedicated MRI (ddMRI) system.
  • Clinical trial validated the system's use in endodontics, periodontics, TMJ, tooth extraction, and orthodontics.
  • The ddMRI provides non-ionizing, high-contrast soft tissue imaging with a dental-specific field of view and average workflow time under 20 minutes.
  • Target users include hospitals, large clinics, and universities; commercial availability is pending and not guaranteed in all countries.
  • Hands-on clinician training is scheduled for April 2026 at the University of Minnesota.

Financial Impact

Long-term revenue opportunity in high-end dental imaging; exact financial impact not disclosed.

revenuemarket_shareR_and_D_roi

Risk Factors

  • Commercial availability is not yet confirmed and subject to regulatory and market rollout constraints.
  • Adoption may be limited due to high cost, infrastructure requirements, and competition from established modalities like CBCT.
  • Revenue contribution is expected to be negligible in the near term; long-term success depends on clinical uptake and reimbursement pathways.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3251807

US Market Status

Market Closed · Opens in 6h 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 9, 2026